This activated status is characterized by increased expression of Ccr7, Mreg, and Fscn1, which have all been previously reported as critical features of immunoregulatory DCs that are enriched in non-small-cell lung cancer and uptake of anti-tumor antigens55. The gene discussed is FSCN1; the disease is neoplasm.